US Drug Recall Register
Class III · Low risk Terminated Initiated Dec 29, 2016 (10 years ago)

Finasteride Tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.

What was recalled

Finasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs, Unit V Polepally, Jadcheria, Mahaboob Nagar - 509 301, India Limited NDC 31722-525-90

Recalling firm
Hetero Drugs Ltd. - Unit 1
NDC code
31722-525-90
Origin
N/A, India
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0453-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Finasteride recalls

See all
Class II · Moderate risk Ongoing

Finasteride Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-6976-3 D-0516-2023
Class II · Moderate risk Terminated

Finasteride

Reason cGMP deviations

Direct Rx NDC 61919-0733-90 D-0477-2023
Class II · Moderate risk Terminated

Finasteride Tablets USP

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Accord Healthcare, Inc. NDC 16729-090-10 D-0392-2023
Class II · Moderate risk Terminated

Finasteride Tablets USP 1 mg

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Accord Healthcare, Inc. NDC 71713-096-90 D-0391-2023